DNA TOPCO LIMITED - Profile & Financials

Accounts Submitted 27 Dec 2024

Confirmation Statement Submitted 12 Mar 2025

Net assets £-44.00M £28.15M 2022 year on year

Total assets £37.28M £3.99M 2022 year on year

Total Liabilities £81.28M £32.14M 2022 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

10 Lower Grosvenor Place London SW1W 0EN United Kingdom

Telephone

0203 633 8655

dpo@dnapaymentsgroup.com

Website

dnapayments.com

Credit Report

Discover DNA TOPCO LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2022

Type Total Exemption Full

Next accounts 31 December 2023

Due by 30 September 2024 9 months

Net Assets, Total Assets & Total Liabilities (2021–2022)

Cash in Bank

£955.40k

Decreased by £15.54M (-94%)

Net Assets

-£44.00M

Decreased by £28.15M (-178%)

Total Liabilities

£81.28M

Increased by £32.14M (+65%)

Turnover

£22.57M

Increased by £10.87M (+93%)

Employees

308

Increased by 165 (+115%)

Debt Ratio

218%

Increased by 70 (+47%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2022 Dec Year End	2021 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

12 Allotments 20,166,472 Shares £20.17m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
6 Jun 2025	B ORDINARY	7	£7	£1
30 May 2024	B ORDINARY	125	£1.25	£0.01
27 Feb 2024	B ORDINARY	10	£10	£1
7 Feb 2024	B ORDINARY	255	£2.55	£0.01
21 Nov 2022	B ORDINARY	20	£20	£1

Officers

4 active 1 resigned

Show resigned officers

						Status
Arif Babayev	Director	British	United Kingdom	42	25 May 2021	Active
Matthias Wilhelm Gradischnig	Director	Austrian	United Kingdom	43	25 May 2021	Active
Nicholas Toby Westcott	Director	British	United Kingdom	47	3 Mar 2021	Active
Nurlan Zhagiparov	Director	Kazakh	Kazakhstan	48	25 May 2021	Active

Shareholders

Shareholders (6)


Nurlan Zhagiparov	0.4%	85,479	Ordinary A2	12 Mar 2025
Dna Midco 1 Limited	0.0%	812	B Ordinary	12 Mar 2025
Aso Victoria 4 S.a.r.l	0.0%	63	B Ordinary	12 Mar 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Alchemy Special Opportunities Llp

Unknown

Active

Notified 3 Mar 2021

Nature of Control

Ownership Of Shares 75 To 100 Percent As Firm
Voting Rights 75 To 100 Percent As Firm
Right To Appoint And Remove Directors As Firm
Significant Influence Or Control

Arif Babayev

Ceased 22 Apr 2023

Ceased

Nurlan Zhagiparov

Ceased 22 Apr 2023

Ceased

See All Controllers

Group Structure

ALCHEMY SPECIAL OPPORTUNITIES LLP united kingdom

DNA TOPCO LIMITED Current Company

DNA MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
25 Jun 2025	Capital	Allotment of shares (GBP 201,664.73) on 2025-06-06	View(8 pages)
12 Mar 2025	Confirmation Statement	Confirmation statement made on 2025-02-28 with updates	View(11 pages)
11 Mar 2025	Capital	Allotment of shares (GBP 201,664.66) on 2024-05-30	View(9 pages)
27 Dec 2024	Accounts	Annual accounts made up to 2023-12-31	View(44 pages)
2 Dec 2024	Officers	Termination of John Paul Bowtell as director on 2024-11-29	View(1 page)